Home › Funds › ORBIMED ADVISORS LLC › ISRG
ORBIMED ADVISORS LLC position in ISRG
INTUITIVE SURGICAL INC · Health Care
ORBIMED ADVISORS LLC reported holding 157,900 shares of ISRG (INTUITIVE SURGICAL INC) in its Q2 2026 13F filing — a position valued at US$62.8M, representing 1.26% of its reported portfolio and ranking #24 among its reported holdings. ORBIMED ADVISORS LLC has disclosed ISRG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's ISRG position evolved
ORBIMED ADVISORS LLC first disclosed a stake in ISRG in Q3 2023 at 499,000 shares (US$145.9M). The position peaked in Q2 2024 at 493,100 shares, worth US$219.4M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 157,900 shares valued at US$62.8M — a reduction of -50,800 shares quarter over quarter.. Notable position changes include a 28% trim in Q1 2025 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 499.00K | $145.85M | New |
| Q4 2023 | 499.00K | $168.34M | Hold |
| Q1 2024 | 493.10K | $196.79M | Reduce |
| Q2 2024 | 493.10K | $219.36M | Hold |
| Q3 2024 | 433.80K | $213.11M | Reduce |
| Q4 2024 | 401.70K | $209.67M | Reduce |
| Q1 2025 | 291.00K | $144.12M | Reduce |
| Q2 2025 | 291.00K | $158.13M | Hold |
| Q3 2025 | 287.20K | $128.44M | Reduce |
| Q4 2025 | 263.40K | $149.18M | Reduce |
| Q1 2026 | 208.70K | $96.21M | Reduce |
| Q2 2026 | 157.90K | $62.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ISRG and 13F data
ISRG (INTUITIVE SURGICAL INC) is a Health Care company. 31 other funds we track also report a position in ISRG — the largest reported positions include Invesco Ltd (US$4.71B), PRICE T ROWE ASSOCIATES INC /MD/ (US$4.48B), ALLIANCEBERNSTEIN L.P. (US$1.67B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ISRG
- Invesco Ltd 11.84M sh · $4.71B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.26M sh · $4.48B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.63M sh · $1.67B · Q2 2026
- Arrowstreet Capital 3.74M sh · $1.49B · Q2 2026
- JENNISON ASSOCIATES LLC 3.67M sh · $1.46B · Q2 2026
- Baillie Gifford & Co 2.52M sh · $1.00B · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held ISRG?
ORBIMED ADVISORS LLC has disclosed ISRG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in ISRG?
As of Q2 2026, ORBIMED ADVISORS LLC holds 157.90K shares of ISRG (INTUITIVE SURGICAL INC), valued at $62.79M, representing 1.26% of its reported portfolio and ranking #24.
Has ORBIMED ADVISORS LLC been buying or selling ISRG?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in ISRG. The position peaked in Q2 2024 at 493.10K shares.
Which other funds hold ISRG?
Other major institutional holders of ISRG include Invesco Ltd, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.